18.12.2024
Swissmedic, the Federal Office for Customs and Border Security (FOCBS) and Swiss Sport Integrity (SSI) confiscated one quarter of more than 1,000 consignments checked
16.12.2024
Five years as national single point of contact (SPOC) for Medicrime Convention
06.12.2024
Eingabefrist: 24. Januar 2025
04.12.2024
With a deadline of 28 February 2025 for comments
04.12.2024
Stakeholders in Switzerland have the possibility to comment on the draft of Guideline M15 “General Principles for Model-Informed Drug Development” until 28 February 2025
28.11.2024
Quicker access to innovative cancer treatments: Swissmedic, the FDA and Swiss professional associations in dialogue
25.11.2024
The outsourcing of IT services is intended to be long-term, for a period up to 2039
22.11.2024
Ongoing Progress in ICH’s Global Harmonisation Initiatives
15.11.2024
Change to the fixed text on the medicinal product's specified indication for complementary medicines
13.11.2024
Illegal slimming tablets or teas and detox products can contain undeclared harmful pharmaceutical substances such as sibutramine
05.11.2024
Health risks of designer drugs: new psychoactive substances added to Narcotics List
01.11.2024
The amended ordinances relating to the Human Research Act enter into force today
17.10.2024
Exports of medicinal products to conflict regions should be organised by established aid organisations
01.10.2024
Swissmedic is changing the name of the “Public Summary SwissPAR” to the “Summary report on authorisation”
17.09.2024
International trends were discussed and the collaboration was strengthened
16.09.2024
Swissmedic publishes instructions on the procedure for submitting applications
13.09.2024
Swissmedic has not received any relevant applications. The assessment of such applications will be given top priority
01.09.2024
A new separate form has been created for notification of no marketing and interruption of distribution for veterinary medicinal products.
01.09.2024
From 1 September 2024, Swissmedic is accepting electronic data sets from pivotal bioequivalence studies for applications for new authorisation of human medicinal products with known active substances without innovation
01.09.2024
From 1 September 2024, Swissmedic will be accepting the submission of films as part of the authorisation of QR codes
01.09.2024
The guidance document Packaging texts for veterinary medicinal products has been revised
01.09.2024
From 1 September 2024, Swissmedic is accepting SEND data sets for applications for new authorisation for human medicinal products with new active substances
01.09.2024
New forms and a new information sheet for submissions to Swissmedic
01.09.2024
To standardise practice, written notification regarding the “Doc. OK” milestone will in future no longer be sent following a formal objection
28.08.2024
Swissmedic is issuing an urgent warning regarding slimming products and other supposedly natural products
26.08.2024
Numerous clarifications have been made in the new version
05.08.2024
Swissmedic has made an initial assessment of the Sarco suicide capsule according to therapeutic products legislation
02.08.2024
Qdenga (powder and solvent for solution for injection in a pre-filled syringe) can be placed on the market in Switzerland
24.07.2024
International comparison of Swiss authorisation times
